The K Ca channel as a trigger for the cardioprotection induced by kappa-opioid receptor stimulation - Its relationship with protein kinase C

British Journal of Pharmacology

Volumn 145, Issue 7, 2005, Pages 984-991

  Cao, Chun Mei ^a   Chen, Mai ^a   Wong, Tak Ming ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Ca 2+ activated potassium channel; Ischaemia and reperfusion; Kappa opioid receptor; Metabolic inhibition and anoxia

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ATRACTYLOSIDE; CALCIUM ACTIVATED POTASSIUM CHANNEL; CHELERYTHRINE; KAPPA OPIATE RECEPTOR; LACTATE DEHYDROGENASE; PAXILLINE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME RELEASE; HEART INFARCTION PREVENTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; CALCIUM; CARDIOTONIC AGENTS; CELL SURVIVAL; HEART; INDOLES; ION CHANNELS; L-LACTATE DEHYDROGENASE; MALE; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, CARDIAC; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA;

EID: 23744437437     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706268     Document Type: Article

References (33)

1. AHMET, I., SAWA, Y., NISHIMURA, M., ICHIKAWA, H. & MATSUDA, H. (2000). Diadenosine tetraphosphate (AP4A) mimics cardioprotective effect of ischemic preconditioning in the rat heart: contribution of KATP channel and PKC. Basic Res. Cardiol., 95, 235-242.
2. BAINES, C.P., GOTO, M. & DOWNEY, J.M. (1997). Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J. Mol. Cell. Cardiol., 29, 207-216.
3. BAINES, C.P., SONG, C.X., ZHENG, Y.T., WANG, G.W., ZHANG, J., WANG, O.L., GUO, Y., BOLLI, R., CARDWELL, E.M. & PING, P. (2003). Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ. Res., 92, 873-880.
4. BERS, D.M. (2000). Calcium fluxes involved in control of cardiac myocyte contraction. Circ. Res., 87, 275-281.
5. CAO, C.M., XIA, Q., GAO, Q., CHEN, M. & WONG, T.M. (2005). Calcium-activated potassium channel triggers cardioprotection of ischemic preconditioning. J. Pharmacol. Exp. Ther., 312, 644-650.
6. CAO, C.M., XIA, Q., TU, J., CHEN, M., WU, S. & WONG, T.M. (2004). Cardioprotection of interleukin-2 is mediated via kappa-opioid receptors. J. Pharmacol. Exp. Ther., 309, 560-567.
7. CHEN, M., ZHOU, J.J., KAM, K.W., QI, J.S., YAN, W.Y., WU, S. & WONG, T.M. (2003). Roles of KATP channels in delayed cardioprotection and intracellular Ca(2+) in the rat heart as revealed by kappa-opioid receptor stimulation with U50488H. Br. J. Pharmacol., 140, 750-758.
8. GRIBKOFF, V.K., LUM-RAGAN, J.T., BOISSARD, C.G., POST-MUNSON, D.J., MEANWELL, N.A., STARRETT JR, J.E., KOZLOWSKI, E.S., ROMINE, J.L., TROJNACKI, J.T., MCKAY, M.C., ZHONG, J. & DWORETZKY, S.I. (1996). Effects of channel modulators on cloned large-conductance calcium-activated potassium channels. Mol. Pharmacol., 50, 206-217.
9. HAUSENLOY, D.J., MADDOCK, H.L., BAXTER, G.F. & YELLON, D.M. (2002). Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc. Res., 55, 534-543.
10. HIEBERT, L. & PING, T. (1997). Protective effect of dextran sulfate and heparin on adult rat cardiomyocytes damaged by free radicals. J. Mol. Cell. Cardiol., 29, 229-235.
11. HO, J.C., WU, S., KAM, K.W., SHAM, J.S. & WONG, T.M. (2002). Effects of pharmacological preconditioning with U50488H on calcium homeostasis in rat ventricular myocytes subjected to metabolic inhibition and anoxia. Br. J. Pharmacol., 137, 739-748.
12. KRIEG, T., COHEN, M.V. & DOWNEY, J.M. (2003). Mitochondria and their role in preconditioning's trigger phase. Basic Res. Cardiol., 98, 228-234.
13. LIANG, B.T. (1997). Protein kinase C-mediated preconditioning of cardiac myocytes: role of adenosine receptor and KATP channel. Am. J. Physiol., 273, H847-H853.
14. LIU, G.S., THORNTON, J., VAN WINKLE, D.M., STANLEY, A.W., OLSSON, R.A. & DOWNEY, J.M. (1991). Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation, 84, 350-356.
15. MURRY, C.E., JENNINGS, R.B. & REIMER, K.A. (1986). Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation, 74, 1124-1136.
16. O'ROURKE, B. (2004). Evidence for mitochondrial K+ channels and their role in cardioprotection. Circ. Res., 94, 420-432.
17. OLESEN, S.P., MUNCH, E., MOLDT, P. & DREJER, J. (1994). Selective activation of Ca(2+)-dependent K+ channels by novel benzimidazolone. Eur. J. Pharmacol., 251, 53-59.
18. PIPER, H.M., MEUTER, K. & SCHAFER, C. (2003). Cellular mechanisms of ischemia-reperfusion injury. Ann. Thorac. Surg., 75, S644-S648.
19. PORTOGHESE, P.S., LIN, C.E., FAROUZ-GRANT, F. & TAKEMORI, A.E. (1994). Structure-activity relationship of N17′-substituted norbinaltorphimine congeners. Role of the N17′ basic group in the interaction with a putative address subsite on the kappa opioid receptor. J. Med. Chem., 37, 1495-1500.
20. SATO, T., SAITO, T., SAEGUSA, N. & NAKAYA, H. (2005). Mitochondrial Ca2+-activated K+ channels in cardiac myocytes: a mechanism of the cardioprotective effect and modulation by protein kinase A. Circulation, 111, 198-203.
21. SCHOFFELMEER, A.N., HOGENBOOM, F. & MULDER, A.H. (1997). Kappa 1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. Br. J. Pharmacol., 122, 520-524.
22. SCHULTZ, J.E., HSU, A.K., BARBIERI, J.T., LI, P.L. & GROSS, G.J. (1998). Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart. Am. J. Physiol, 275, H495-H500.
23. SHENG, J.Z., WONG, N.S., WANG, H.X. & WONG, T.M. (1997). Pertussis toxin, but not tyrosine kinase inhibitors, abolishes effects of U-50488H on [Ca2+]i in myocytes. Am. J. Physiol., 272, C560-C564.
24. + channels is involved in ischemic preconditioning in canine hearts. J. Mol. Cell. Cardiol., 37, 1213-1218.
25. SPEECHLY-DICK, M.E., MOCANU, M.M. & YELLON, D.M. (1994). Protein kinase C. Its role in ischemic preconditioning in the rat. Circ. Res., 75, 586-590.
26. WANG, G.Y., WU, S., PEI, J.M., YU, X.C. & WONG, T.M. (2001a). Kappa- but not delta-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats. Am. J. Physiol. Heart Circ. Physiol., 280, H384-H391.
27. WANG, G.Y., ZHOU, J.J., SHAN, J. & WONG, T.M. (2001b). Protein kinase C-epsilon is a trigger of delayed cardioprotection against myocardial ischemia of kappa-opioid receptor stimulation in rat ventricular myocytes. J. Pharmacol. Exp. Ther., 299, 603-610.
28. WEISS, J.N., KORGE, P., HONDA, H.M. & PING, P. (2003). Role of the mitochondrial permeability transition in myocardial disease. Circ. Res., 93, 292-301.
29. WU, S., LI, H.Y. & WONG, T.M. (1999). Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor. Circ. Res., 84, 1388-1395.
30. XU, M., WANG, Y., HIRAI, K., AYUB, A. & ASHRAF, M. (2001). Calcium preconditioning inhibits mitochondrial permeability transition and apoptosis. Am. J. Physiol. Heart Circ. Physiol., 280, H899-H908.
31. + channels in the cardiac inner mitochondrial membrane. Science, 298, 1029-1033.
32. YU, X.C., LI, H.Y., WANG, H.X. & WONG, T.M. (1998). U50,488H inhibits effects of norepinephrine in rat cardiomyocytes-cross-talk between kappa-opioid and beta-adrenergic receptors. J. Mol. Cell. Cardiol., 30, 405-413.
33. ZHOU, X., ZHAI, X. & ASHRAF, M. (1996). Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation, 93, 1177-1184.